Dr. Scott Kellam Adney, MD

Dr. Adney practices at Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD in Chicago, Illinois.

Dr. Adney's NPI, 1467847251, was assigned on March 30, 2015. Dr. Adney holds Illinois license 036148993.

Dr. Adney's primary practice is Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD, at 259 E Erie St, Chicago, IL 60611.

Dr. Adney's primary practice is Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD in Chicago, Illinois. Dr. Adney is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Adney to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Adney's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adney practices, 5 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Adney's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Adney is licensed in Illinois.

CMS data shows 115 Medicare services from Dr. Adney across 3 procedure codes in 2024, for 76 Medicare patients. Medicare paid $17,144 for them.

CMS counts 76 Medicare patients who saw Dr. Adney in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adney's median patient age at 66, with 59% women.

In 2024, Dr. Adney wrote 334 Medicare Part D claims for 46 patients. 72% of them were for generic drugs. CMS names the drug for 303 of them, across 8 drugs with 11 or more claims each, at $144,763 in total drug cost. In 2023, CMS named 202 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Adney for performance year 2024, reported through an alternative payment model (APM). Dr. Adney accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Adney as offering telehealth.

Dmand AI links 10 papers to Dr. Adney, published from 2012 to 2024. 2012 was the busiest year, with 3. The most frequent topics are Phosphatidylinositol 4,5-Diphosphate, Ion Channel Gating and Oocytes. Dr. Adney's most frequent co-authors are Junghoon Ha, MD, PhD, Rahul Mahajan, MD, PhD and Sarah Kathleen Bandt, MD.

CMS Open Payments shows 8 general payments to Dr. Adney from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 96% of the total. LivaNova USA, Inc. paid the most, $189.